Ignite Creation Date:
2025-12-25 @ 2:56 AM
Ignite Modification Date:
2026-02-07 @ 10:41 PM
Study NCT ID:
NCT01015833
Status:
COMPLETED
Last Update Posted:
2022-08-04
First Post:
2009-11-17
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer
Sponsor:
National Cancer Institute (NCI)
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Advanced Adult Hepatocellular Carcinoma | View |
| None | Recurrent Hepatocellular Carcinoma | View |
| None | Stage III Hepatocellular Carcinoma AJCC v7 | View |
| None | Stage IIIA Hepatocellular Carcinoma AJCC v7 | View |
| None | Stage IIIB Hepatocellular Carcinoma AJCC v7 | View |
| None | Stage IIIC Hepatocellular Carcinoma AJCC v7 | View |
| None | Stage IV Hepatocellular Carcinoma AJCC v7 | View |
| None | Stage IVA Hepatocellular Carcinoma AJCC v7 | View |
| None | Stage IVB Hepatocellular Carcinoma AJCC v7 | View |
| None | Unresectable Hepatocellular Carcinoma | View |
Keywords: